A detailed history of Mendota Financial Group, LLC transactions in Viatris Inc stock. As of the latest transaction made, Mendota Financial Group, LLC holds 5,169 shares of VTRS stock, worth $60,012. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,169
Previous 5,169 -0.0%
Holding current value
$60,012
Previous $61.7 Million 10.97%
% of portfolio
0.03%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$11.27 - $13.53 $7,460 - $8,956
662 Added 14.69%
5,169 $61.7 Million
Q2 2023

Jul 27, 2023

BUY
$9.02 - $10.29 $14,035 - $16,011
1,556 Added 52.73%
4,507 $45 Million
Q2 2023

Jul 25, 2023

SELL
$9.02 - $10.29 $685 - $782
-76 Reduced 2.51%
2,951 $32.1 Million
Q1 2023

Apr 24, 2023

SELL
$9.2 - $12.26 $18 - $24
-2 Reduced 0.07%
3,027 $32.9 Million
Q4 2022

Feb 03, 2023

BUY
$8.72 - $11.56 $26,412 - $35,015
3,029 New
3,029 $33.7 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Mendota Financial Group, LLC Portfolio

Follow Mendota Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mendota Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mendota Financial Group, LLC with notifications on news.